Myriad Genetics, Inc. (MYGN)
6.04
+0.19
(+3.25%)
USD |
NASDAQ |
Nov 03, 16:00
6.04
0.00 (0.00%)
After-Hours: 17:15
Myriad Genetics Price to Book Value : 1.900 for Nov. 3, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 1.840 |
| October 30, 2026 | 1.998 |
| October 29, 2026 | 2.098 |
| October 28, 2026 | 2.086 |
| October 27, 2026 | 1.979 |
| October 26, 2026 | 1.894 |
| October 23, 2026 | 1.831 |
| October 22, 2026 | 1.812 |
| October 21, 2026 | 1.752 |
| October 20, 2026 | 1.743 |
| October 19, 2026 | 1.324 |
| October 16, 2026 | 1.252 |
| October 15, 2026 | 1.368 |
| October 14, 2026 | 1.306 |
| October 13, 2026 | 1.284 |
| October 12, 2026 | 1.321 |
| October 09, 2026 | 1.356 |
| October 08, 2026 | 1.321 |
| October 07, 2026 | 1.346 |
| October 06, 2026 | 1.346 |
| October 05, 2026 | 1.441 |
| October 02, 2026 | 1.428 |
| October 01, 2026 | 1.277 |
| September 30, 2026 | 1.356 |
| September 29, 2026 | 1.331 |
| Date | Value |
|---|---|
| September 28, 2026 | 1.334 |
| September 25, 2026 | 1.312 |
| September 24, 2026 | 1.302 |
| September 23, 2026 | 1.262 |
| September 22, 2026 | 1.265 |
| September 21, 2026 | 1.262 |
| September 18, 2026 | 1.224 |
| September 17, 2026 | 1.302 |
| September 16, 2026 | 1.214 |
| September 15, 2026 | 1.221 |
| September 14, 2026 | 1.192 |
| September 11, 2026 | 1.076 |
| September 10, 2026 | 1.057 |
| September 09, 2026 | 1.004 |
| September 08, 2026 | 1.000 |
| September 04, 2026 | 1.004 |
| September 03, 2026 | 1.016 |
| September 02, 2026 | 1.016 |
| September 01, 2026 | 1.000 |
| August 31, 2026 | 1.013 |
| August 28, 2026 | 0.9941 |
| August 27, 2026 | 1.000 |
| August 26, 2026 | 0.9815 |
| August 25, 2026 | 1.004 |
| August 24, 2026 | 0.9595 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Labcorp Holdings, Inc. | 3.248 |
| Natera, Inc. | 30.63 |
| Sera Prognostics, Inc. | 1.322 |
| BioRestorative Therapies, Inc. | 0.6357 |
| CareDx, Inc. | 9.930 |
Price to Book Value Related Metrics
| PS Ratio | 0.7019 |
| Price | 6.04 |
| Earnings Yield | -19.84% |
| Market Cap | 577.42M |